Overview

Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-Effects

Status:
Unknown status
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether increasing blood levels of androgen can reduce some of the side-effects of anti-estrogen therapy (Arimidex)
Phase:
Phase 2
Details
Lead Sponsor:
Chavah Pty Ltd
Havah Therapeutics Pty Ltd
Collaborator:
AstraZeneca
Treatments:
Anastrozole
Aromatase Inhibitors
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate